On Tap For Tue Dec 19, 2006
The following are some of the NYSE stocks that I will be keeping an eye on and possibly trading tomorrow. Obviously there may be news on other stocks that come out overnight or in the morning, so I may be trading those stocks as well.Here's my list:
- Homebuilder Hovnanian Enterprises Inc. (HOV) reported after the close and swung to a Q4 loss - it was trading lower by 3.6% in after-hours
- In after-hours Pfizer Inc. (PFE) said it was increasing it's dividend by 21%
- The world's #3 cement maker Cemex (CX) provided guidance for the fourth quarter after the bell today
- Circuit City Stores Inc. (CC) and Darden Restaurants Inc. (DRI) are both expected to report tomorrow
- Eli Lilly & Co. (LLY) had a number of things going on today (upped dividend, upped it's buyout offer of ICOS, reports of questionable marketing practices for Zyprexa) - it traded down today and might break out of this trading range to the downside
- Realogy Corporation (H) was up over 19% today after it said it was being acquired by a private equity group for $6.6 billion
- Weight Watcher International Inc. (WTW) was also up today after the company announced it was buying back 8.3 million shares for between $47 - $54 per share
- L-3 Communications Holdings Inc. (LLL) traded lower today after it lowered guidance after losing a major US Army contract worth about $4.6 billion
- I'm also watching these stocks: General Electric Company (GE) (continues to look strong), Citigroup Inc. (C) (also still strong, upgraded by Merrill today), Harrah's Entertainment Inc. (HET) (see where it goes after agreeing to buyout offer), Terex Corporation (TEX) (was strong today, will be added to S&P500 after close tomorrow), Caremark Rx Inc. (CMX) (seeing where it goes after a buyout offer made by Express Scripts), and American International Group Inc. (AIG) (new 52-week high, mentioned by Cramer, chart looks interesting)
Labels: on tap, stocks to watch
posted by J.C. at
10:07 p.m.
2 Comments:
Eli Lilly Zyprexa scandal
Zyprexa off label promotion scandal is all over the news now.
Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa".
Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.
Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.
The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.
Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.
---
Daniel Haszard zyprexa-victims.com
By
Anonymous, at December 19, 2006 5:14 a.m.
Daniel,
Thanks for your comments and thanks for the update. In fact, I'd encourage more people like yourself to add their take on stocks in the news - especially in my On Tap posts so that others can get a clearer picture of what's going on.
Best of luck to you!
By
J.C., at December 19, 2006 7:18 a.m.
Post a Comment
<< Home